.
11 febrero 2021
Celltrion Develops Tailored Neutralising Antibody Cocktail Treatment with CT-P59 to Tackle COVID-19 Variant Spread Using Its Antibody Development Platform .
Entrada más reciente
Entrada antigua
Inicio